Riccardo Lencioni MD, FSIR, EBIR

Dr. Riccardo Lencioni, MD, FSIR, EBIR, is a Professor and Director of Diagnostic Imaging and Intervention at Pisa University School of Medicine in Pisa, Italy. Lencioni is one of the world’s foremost interventional oncology specialists, known especially for his highly influential work in liver cancer. He has been the principal investigator of several large, multicenter, randomized clinical trials investigating the use of image-guided interventions for the treatment of hepatocellular carcinoma and the potential synergies between loco-regional and systemic therapies. Professor Lencioni has been a leading member of several expert panels developing recommendations for research and clinical management of hepatocellular carcinoma. He is also known for having developed modified RECIST (mRECIST) criteria for the assessment of tumor response in hepatocellular carcinoma. 

He completed his Doctor of Medicine at the University of Pisa, Italy 1986, his Certification in gastroenterology at the University of Pisa, Italy 1990, a Postgraduate degree in diagnostic ultrasound, at the University of Pisa, Italy 1990, and his Certification in radiology at the University of Pisa, Italy 1994.

Riccardo Lencioni has published more than 200 articles in peer-reviewed international journals indexed in PubMed and numerous chapters in textbooks of radiology, gastroenterology, oncology, and surgery. In addition, he has been the editor of nine books. According to the SCOPUS database, citations of his publications currently number in excess of 26,000, for an h-index of 67.